Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) has announced its participation in the upcoming Guggenheim Securities Healthcare Innovation Conference in Boston on November 12, 2024. Krish S. Krishnan, Chairman and CEO, will participate in a fireside chat at 1:30 pm ET and conduct investor meetings throughout the day. The presentation will be accessible via webcast and will be available on the company's Investors section of their website.

News Market Reaction – KRYS

+4.98%

+4.98% Session move

In the trading session that priced this news, KRYS gained 4.98%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim Securities Healthcare Innovation Conference on November 12, 2024, in Boston. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:30 pm ET and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 1:30 pm ET on Tuesday, November 12, 2024 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:                                                                                        
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com                                                                                   

FAQ

When is Krystal Biotech (KRYS) presenting at the Guggenheim Securities Healthcare Conference 2024?

Krystal Biotech will present at the Guggenheim Securities Healthcare Innovation Conference on November 12, 2024, at 1:30 pm ET in Boston.

Will the Krystal Biotech (KRYS) Guggenheim Conference presentation be available online?

Yes, a webcast of the presentation will be available on the Investors section of Krystal Biotech's website, starting at 1:30 pm ET on November 12, 2024.

What type of presentation will Krystal Biotech (KRYS) give at the Guggenheim Healthcare Conference?

Krystal Biotech's Chairman and CEO Krish S. Krishnan will participate in a fireside chat and host investor meetings throughout the day.